| # | Holder | Shares | Value | % of shares out | Δ QoQ |
|---|---|---|---|---|---|
| 1 | CENTRAL BANK & TRUST CO | 5,1685,168 | $218,233 | — | — |
Rows rank by the value each filer reported — 13F filers price their own positions, so a holder with fewer shares can rank just above one with more.
| Holder | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| CENTRAL BANK & TRUST CO | — | — | — | 5K | 5K | 5K | $218,233 |
Shares reported each quarter by the largest current holders. Green = added vs the prior filing, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Holder count only — too few computable %-of-shares-outstanding quarters for a % pane. Line breaks are quarters with no 13F record, never interpolated.
| Quarter | Holders | Shares held | % shares out | Value held |
|---|---|---|---|---|
| 2026-Q1 | 1 | 5,168 | — | $218,233 |
| 2025-Q4 | 2 | 5,541 | — | $233,876 |
| 2025-Q3 | 1 | 5,168 | — | $207,640 |
| 2024-Q3 | 1 | 5,168 | — | $221,282 |
| 2021-Q4 | 1 | 9,128 | — | $387,000 |
| 2020-Q4 | 1 | 5,162 | — | $209,000 |
| 2019-Q4 | 1 | 9,264 | — | $345,000 |
| 2018-Q3 | 1 | 14,962 | — | $598,000 |
| 2016-Q2 | 1 | 479 | — | $17,639 |
| 2015-Q4 | 2 | 5,740 | — | $211,960 |
| 2015-Q3 | 1 | 5,146 | — | $193,000 |
| 2015-Q2 | 1 | 5,146 | — | $229,000 |
| 2015-Q1 | 1 | 5,146 | — | $227,000 |
| 2014-Q4 | 1 | 5,146 | — | $222,000 |
| 2014-Q2 | 1 | 4,159 | — | $220,000 |
| 2014-Q1 | 1 | 4,159 | — | $213,000 |
| 2013-Q4 | 1 | 4,159 | — | $209,000 |
| 2013-Q3 | 1 | 4,309 | — | $205,000 |
| 2013-Q2 | 1 | 4,309 | — | $205,000 |
Short interest has its own tab now — open SI →
Source: SEC Form 13F — every institution manager (≥ $100M in 13F securities) reporting a long US-listed position, across ~10,250 filers over 10 years of history. 13F is long-only, US-listed, filed up to 45 days after quarter-end.